French biomedical firm Carmat confirmed on Tuesday it would implant its experimental artificial heart into another three people, as planned, after the first recipient of the artificial heart died. In an email to AFP, the company said it was too soon to draw conclusions about the device's efficacy. A 76-year-old recipient died over the weekend, 75 days after receiving the gadget, whose trials are being closely followed by French investors. "It ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1dq04ki
No comments:
Post a Comment